Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 98Stomach Neoplasms 50Rectal Neoplasms 45Pancreatic Neoplasms 45Colonic Neoplasms 36Esophageal Neoplasms 34Neoplasms 30Neoplasm Metastasis 28Squamous Cell Carcinoma of Head and Neck 27Head and Neck Neoplasms 24Breast Neoplasms 21Adenocarcinoma Of Esophagus 20Parkinson Disease 4, Autosomal Dominant Lewy Body 12Adenocarcinoma 9Anus Neoplasms 8Esophageal Squamous Cell Carcinoma 7Carcinoma, Squamous Cell 7Carcinoma 7Cholangiocarcinoma 6Liver Neoplasms 5Gallbladder Neoplasms 5Bile Duct Neoplasms 5Urinary Bladder Neoplasms 4Pancreatic Adenocarcinoma 4Gastrointestinal Neoplasms 4Carcinoma, Hepatocellular 4Skin Neoplasms 3Sarcoma 3Peritoneal Neoplasms 3Laryngeal Neoplasms 3

Interventions

Gemcitabine 4pembrolizumab 2Leucovorin 2Irinotecan 2Fluorouracil 2Albumin-Bound Paclitaxel 24-fluorobenzoyl-TN-14003 2regorafenib 1olaparib 1irinotecan sucrosofate 1ibrutinib 1adavosertib 1Paclitaxel 1PEGPH20 1Oxaliplatin 1Drug Therapy 1Docetaxel 1Cisplatin 1Capecitabine 1BKT140 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Metastatic Pancreatic Adenocarcinoma × Fluorouracil × Clear all
NCT02826486 2024-08-28

COMBAT

BioLineRx, Ltd.

Phase 2 Completed
80 enrolled 13 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT01959139 2024-02-09

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

SWOG Cancer Research Network

Phase 1/2 Completed
126 enrolled 19 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡